Mable

Acquired

First personalized migraine clinic using genetics and telehealth.

San Francisco, United States · Founded 2019 · $3.3M raised

Employees
1–10
Founded
2019
Total Funding
$3.3M
Last Round
$3.2M SeedJul 2022
Rounds
2

About

Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.

Summary

Mable is a Digital Health company based in San Francisco, United States, founded in 2019. It has raised $3.3M in total across 2 rounds, most recently a $3.2M Seed round in Jul 2022. Investors include Initialized Capital and Y Combinator Continuity Fund.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJul 2022
$3.2M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies